The US Food and Drug Administration stated Friday it has realized some ranitidine — acid-reducing and heartburn medicines, including those known by the imprint name Zantac — maintain low ranges of an impurity that would trigger cancer.
The nitrosamine impurity known…
Learn Extra
FDA finds low levels of cancer-linked impurity in common heartburn drugs – WJW FOX 8 News Cleveland
Leave a comment
Sign in to post your comment or sign-up if you don't have any account.